Home » BIOGEN IDEC TO EXPAND ONCOLOGY PIPELINE
BIOGEN IDEC TO EXPAND ONCOLOGY PIPELINE
Biogen Idec and Conforma Therapeutics Corporation, a privately held biopharmaceutical company focused on the design and development of novel drugs for the treatment of cancer, recently announced that they have signed a definitive merger agreement for the acquisition of Conforma by Biogen Idec.
Financial News USA
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May